AU2023902106A0 - Peptides and Their Use in Diagnosis - Google Patents

Peptides and Their Use in Diagnosis

Info

Publication number
AU2023902106A0
AU2023902106A0 AU2023902106A AU2023902106A AU2023902106A0 AU 2023902106 A0 AU2023902106 A0 AU 2023902106A0 AU 2023902106 A AU2023902106 A AU 2023902106A AU 2023902106 A AU2023902106 A AU 2023902106A AU 2023902106 A0 AU2023902106 A0 AU 2023902106A0
Authority
AU
Australia
Prior art keywords
peptides
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023902106A
Inventor
Bror Samuel LUNDIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotome Pty Ltd
Original Assignee
Biotome Pty Ltd
Filing date
Publication date
Application filed by Biotome Pty Ltd filed Critical Biotome Pty Ltd
Publication of AU2023902106A0 publication Critical patent/AU2023902106A0/en
Pending legal-status Critical Current

Links

AU2023902106A 2023-06-30 Peptides and Their Use in Diagnosis Pending AU2023902106A0 (en)

Publications (1)

Publication Number Publication Date
AU2023902106A0 true AU2023902106A0 (en) 2023-07-20

Family

ID=

Similar Documents

Publication Publication Date Title
EP4119162A4 (en) Pvrig binding protein and its medical uses
EP4095148A4 (en) Anti-trop-2 antidody-exatecan analog conjugate and medical use thereof
EP3800193A4 (en) Peptide having skin whitening activity and use thereof
EP4012019A4 (en) Bifidobacterium breve 207-1 and use thereof
EP3849580A4 (en) Modified peptide fragments of cav-1 protein and the use thereof in the treatment of fibrosis
EP3964531A4 (en) Protein molecule and use thereof
EP3999544A4 (en) Polypeptide complex for conjugation and use thereof
EP3938051A4 (en) Peptidomimetic macrocycles and uses thereof
AU2023902106A0 (en) Peptides and Their Use in Diagnosis
AU2023902104A0 (en) Peptides and Their Use in Diagnosis
AU2022900536A0 (en) Peptides and their use in diagnosis
AU2022900537A0 (en) Peptides and their use in diagnosis
AU2021900617A0 (en) Peptides and their use in diagnosis
AU2021900616A0 (en) Peptides and their use in diagnosis
AU2020900887A0 (en) Peptides and their use in diagnosis
AU2020900885A0 (en) Peptides and their use in diagnosis
EP3800194A4 (en) Peptide having skin whitening activity and use thereof
EP3967748A4 (en) Nanocellulose 3d matrix for cultivating human and animal cells in vitro
EP3946451A4 (en) Fibroblast activation protein binding agents and use thereof
EP4032611A4 (en) Composite material and use thereof in desulfurization
AU2021900506A0 (en) Peptides and their use in diagnosis of SARS-CoV-2 infection
EP3984595A4 (en) Peptide and use thereof
AU2021305309A1 (en) Macrocycles and their use
AU2022900994A0 (en) Conjugates and their use in therapy
AU2022392824A1 (en) Peptides and uses thereof